PA
Patwa Anmol Ajaybhai
About Patwa Anmol Ajaybhai
Data last updated:
Patwa Anmol Ajaybhai is a Designated Partner at Acme Lifetech Llp (since 2025), Director at Mahashakti Rasayan Pvt Ltd (since 2013) and Director at Neovant Therapeutics Private Limited (since 2023), and holds 5 more current directorships. The companies operate in Pharma, Healthcare and FMCG. The 4 current companies with reported revenue have a combined latest revenue of ₹117 Cr; the largest is Acme Lifetech Llp at ₹93.26 Cr (FY 2024). Earlier, Patwa Anmol Ajaybhai was a Designated Partner at Acaris Health Llp (2021–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Acme Lifetech Llp AAD-9246 | Designated Partner | 30 Jun 2025 | 2015 | ₹93.26 Cr (FY 2024) | Active |
| Mahashakti Rasayan Pvt Ltd U24231GJ1989PTC012529 | Director | 29 Nov 2013 | 1989 | ₹20.43 Cr (FY 2025) | Active |
| Neovant Therapeutics Private Limited U21002GJ2023PTC138826 | Director | 10 Mar 2023 | 2023 | ₹2.66 Cr (FY 2025) | Active |
| Nuway Medsolutions Private Limited U47721GJ2024PTC155277 | Director | 23 Sep 2024 | 2024 | ₹29.9 Lakh (FY 2025) | Active |
| Acme Pharmaceuticals India Private Limited U21002GJ2025PTC168849 | Director | 17 Oct 2025 | 2025 | Active | |
| Acme Pharmaceuticals Private Limited U21002GJ2025PTC161971 | Director | 23 Apr 2025 | 2025 | Active | |
| Acme Pharmaceuticals & Health Llp AAY-8909 | Designated Partner | 05 Oct 2021 | 2021 | Active | |
| Acme Pharmacy Llp AAY-6489 | Designated Partner | 17 Sep 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Acaris Health Llp AAZ-2883 | Designated Partner | 30 Oct 2021 | 2021 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Patwa Anmol Ajaybhai
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dashrathbhai Kalidas Patel | 00155539 | Acme Lifetech Llp , Neovant Therapeutics Private Limited and 4 more | Designated Partner |
| Aashil Jayvant Patel | 01520597 | Mahashakti Rasayan Pvt Ltd | Director |
| Ajay Patwa Jaswantlal | 01462860 | Mahashakti Rasayan Pvt Ltd | Director |
| Amee Patwa | 01535632 | Mahashakti Rasayan Pvt Ltd | Director |
| Dilip Shankarbhai Chaudhary | 01354482 | Neovant Therapeutics Private Limited | Director |
| Jagdish Madhavlal Chaudhary | 01687830 | Neovant Therapeutics Private Limited | Director |
| Nirav Pravinkumar Trivedi | 07305698 | Neovant Therapeutics Private Limited | Director |
| Ramakrishna Guduru | 09464093 | Neovant Therapeutics Private Limited | Director |
| Umesh Vinayakrao Barabde | 10347239 | Neovant Therapeutics Private Limited | Director |
| Vishakh Ramrao Kharat | 10367869 | Neovant Therapeutics Private Limited | Director |
| Krunal Rajeshbhai Thakkar | 09575484 | Acme Pharmacy Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Patwa Anmol Ajaybhai
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Patwa Anmol Ajaybhai
Patwa Anmol Ajaybhai currently holds 8 directorships: Acme Lifetech Llp (Designated Partner, since 30 Jun 2025, revenue ₹93.26 Cr (FY 2024)); Mahashakti Rasayan Pvt Ltd (Director, since 29 Nov 2013, revenue ₹20.43 Cr (FY 2025)); Neovant Therapeutics Private Limited (Director, since 10 Mar 2023, revenue ₹2.66 Cr (FY 2025)); Nuway Medsolutions Private Limited (Director, since 23 Sep 2024, revenue ₹29.9 Lakh (FY 2025)); Acme Pharmaceuticals India Private Limited (Director, since 17 Oct 2025); and 3 more.
Patwa Anmol Ajaybhai was first appointed on 29 Nov 2013 as Director at Mahashakti Rasayan Pvt Ltd. The most recent appointment on record is 17 Oct 2025 at Acme Pharmaceuticals India Private Limited.
The 4 current companies of Patwa Anmol Ajaybhai that report revenue have a combined latest revenue of ₹117 Cr: Acme Lifetech Llp ₹93.26 Cr (FY 2024); Mahashakti Rasayan Pvt Ltd ₹20.43 Cr (FY 2025); Neovant Therapeutics Private Limited ₹2.66 Cr (FY 2025); Nuway Medsolutions Private Limited ₹29.9 Lakh (FY 2025).
Patwa Anmol Ajaybhai held 1 earlier board appointment: Acaris Health Llp (Designated Partner, 30 Oct 2021 to 25 Jan 2025).
The current boards of Patwa Anmol Ajaybhai's companies include Dashrathbhai Kalidas Patel (Acme Lifetech Llp), Aashil Jayvant Patel (Mahashakti Rasayan Pvt Ltd), Ajay Patwa Jaswantlal (Mahashakti Rasayan Pvt Ltd), Amee Patwa (Mahashakti Rasayan Pvt Ltd), Dilip Shankarbhai Chaudhary (Neovant Therapeutics Private Limited), Jagdish Madhavlal Chaudhary (Neovant Therapeutics Private Limited), among others.